UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 166 filers reported holding UNIQURE NV in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $331,000 | -55.6% | 15,980 | -31.4% | 0.01% | -58.8% |
Q3 2021 | $745,000 | +3.8% | 23,281 | -0.1% | 0.03% | +6.2% |
Q2 2021 | $718,000 | -7.4% | 23,314 | +1.4% | 0.03% | -11.1% |
Q1 2021 | $775,000 | -7.3% | 23,002 | -0.6% | 0.04% | -12.2% |
Q4 2020 | $836,000 | -2.1% | 23,136 | -0.2% | 0.04% | -10.9% |
Q3 2020 | $854,000 | – | 23,175 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 955,424 | $32,188,000 | 5.82% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 282,034 | $9,490,000 | 2.51% |
Nantahala Capital Management | 1,672,891 | $56,360,000 | 1.65% |
Henry James International Management Inc. | 149,053 | $5,022,000 | 1.51% |
Nantahala Capital Management | 1,500,000 | $50,535,000 | 1.48% |
Voss Capital, LLC | 90,000 | $3,032,000 | 1.26% |
P.A.W. CAPITAL CORP | 30,000 | $1,011,000 | 0.89% |
Sofinnova Investments, Inc. | 427,122 | $14,390,000 | 0.86% |
Caption Management, LLC | 1,078,800 | $36,343,000 | 0.78% |
Sivik Global Healthcare LLC | 61,768 | $2,081,000 | 0.76% |